SynaptixBio’s fourth anniversary celebrated in The Lifesciences MagazineDr Dan Williams5 days ago1 min readSynaptixBio: Four Years Of Rare Disease Research Excellence | The Lifesciences Magazine
In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapies
In a major article for Pharmaceutical Market Europe, SynaptixBio explains the science behind gene silencing technology
Comments